Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statins in the treatment of depression: Hype or hope?
Ole Köhler‐Forsberg, Christian Otte, Stefan M. Gold, et al.
Pharmacology & Therapeutics (2020) Vol. 215, pp. 107625-107625
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 203
Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management
Michael Berk, Ole Köhler‐Forsberg, Megan Turner, et al.
World Psychiatry (2023) Vol. 22, Iss. 3, pp. 366-387
Open Access | Times Cited: 104
Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization
Di Yao, Rong Li, Jiahuan Hao, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 32
“Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression
Yishu Yin, Ting Ju, Deyong Zeng, et al.
Pharmacological Research (2024) Vol. 207, pp. 107322-107322
Open Access | Times Cited: 15
Association between atherogenic index of plasma and depressive symptoms in US adults: Results from the National Health and Nutrition Examination Survey 2005 to 2018
Zhiqiang Ye, Wenjie Huang, Jianing Li, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 239-247
Closed Access | Times Cited: 8
Brain-immune crosstalk in the treatment of major depressive disorder
Igor Branchi, S. Poggini, Lucile Capuron, et al.
European Neuropsychopharmacology (2020) Vol. 45, pp. 89-107
Open Access | Times Cited: 56
Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies
Riccardo De Giorgi, Nicola Rizzo Pesci, Alice M. G. Quinton, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 37
The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders
Michał Kosowski, Joanna Smolarczyk-Kosowska, Marcin Hachuła, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2838-2838
Open Access | Times Cited: 33
Blood-derived factors to brain communication in brain diseases
Jiachen He, Yanming Zhang, Yansu Guo, et al.
Science Bulletin (2024) Vol. 69, Iss. 22, pp. 3618-3632
Open Access | Times Cited: 5
Polydatin Prevents Neuroinflammation and Relieves Depression via Regulating Sirt1/HMGB1/NF-κB Signaling in Mice
Hetao Bian, Ling Xiao, Liang Liang, et al.
Neurotoxicity Research (2022) Vol. 40, Iss. 5, pp. 1393-1404
Closed Access | Times Cited: 19
Clinical symptoms, thyroid dysfunction, and metabolic disturbances in first-episode drug-naïve major depressive disorder patients with suicide attempts: A network perspective
Pu Peng, Qianjin Wang, Xiaoe Lang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
The pharmacological bases for repurposing statins in depression: a review of mechanistic studies
Riccardo De Giorgi, Nicola Rizzo Pesci, Gianluca Rosso, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder
Wenjun Su, Ting Hu, Chun‐Lei Jiang
Current Neuropharmacology (2023) Vol. 22, Iss. 5, pp. 810-842
Closed Access | Times Cited: 12
Efficacy and acceptability of anti-inflammatory agents in major depressive disorder: a systematic review and meta-analysis
Yue Du, Yikai Dou, Min Wang, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 4
Protective effects of statins on pulmonary function in patients with persistent hyperlipidemia: a retrospective cohort study
Hsiao‐Chin Shen, Chih‐Wei Tseng, Yi-Hsuan Lin, et al.
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
The Role of Pharmacotherapy in the Management of Comorbidities
István Bitter, Pavel Mohr, Matej Štuhec
(2025), pp. 411-430
Closed Access
Transforming the evidence landscape in mental health with platform trials
Stefan M. Gold, Fanni-Laura Mäntylä, Kim Donoghue, et al.
Nature Mental Health (2025)
Closed Access
Statins: Neurobiological underpinnings and mechanisms in mood disorders
Adam J. Walker, Yesul Kim, Igor Borissiouk, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 693-708
Closed Access | Times Cited: 25
The effects of statin monotherapy on depressive symptoms: A systematic review and meta-analysis
Riccardo De Giorgi, Shona Waters, Nicola Rizzo Pesci, et al.
Journal of Affective Disorders (2022) Vol. 311, pp. 336-343
Open Access | Times Cited: 14
Targeted drug delivery systems to control neuroinflammation in central nervous system disorders
Negin Mozafari, Hajar Ashrafi, Amir Azadi
Journal of Drug Delivery Science and Technology (2021) Vol. 66, pp. 102802-102802
Closed Access | Times Cited: 20
Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression
Malcolm Forbes, Adrienne O’Neil, Melissa M. Lane, et al.
Drugs & Aging (2021) Vol. 38, Iss. 6, pp. 451-467
Closed Access | Times Cited: 19
Gender difference in the relationship between clinical symptoms, thyroid hormones, and metabolic parameters in young, first-episode and drug-naïve major depressive disorder patients with suicide attempts: a network analysis perspective
ZhaoXuan Shang, ChunQing Fang, Guoshuai Luo, et al.
Journal of Psychiatric Research (2024) Vol. 176, pp. 411-421
Closed Access | Times Cited: 2
Effects of various statins on depressive symptoms: A network meta-analysis
Ming‐Chia Lee, Tzu‐Rong Peng, Bi-Li Chen, et al.
Journal of Affective Disorders (2021) Vol. 293, pp. 205-213
Closed Access | Times Cited: 14
Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study
Riccardo De Giorgi, Franco De Crescenzo, Philip J. Cowen, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Exploring the role of serum lipid profile and neutrophil-to-lymphocyte ratio in violent suicide attempters: a cross sectional study
Enrico Capuzzi, Alice Caldiroli, Martina Capellazzi, et al.
CNS Spectrums (2020) Vol. 27, Iss. 3, pp. 362-368
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top